Neuroblastoma
- 1 June 2000
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 59 (6) , 1261-1277
- https://doi.org/10.2165/00003495-200059060-00006
Abstract
Neuroblastoma represents one of the most challenging malignancies for treatment decisions because of its unusual biological behaviour. The features include spontaneous regression (regressive type),...Keywords
This publication has 53 references indexed in Scilit:
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusionsEuropean Journal Of Cancer, 1997
- Positive Selection and Transplantation of Peripheral CD34+ Progenitor Cells: Feasibility and Purging Efficacy in Pediatric Patients with NeuroblastomaJournal of Hematotherapy, 1997
- A population-based study of the usefulness of screening for neuroblastomaThe Lancet, 1996
- Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastomaMedical and Pediatric Oncology, 1995
- Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitroEuropean Journal Of Cancer, 1995
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experienceKlinische Padiatrie, 1990
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- DIFFERENTIATION OF NEUROBLASTOMA CELLS IN CULTUREBiological Reviews, 1975